ValueSet Comparison between http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TNMStageGroupVS vs http://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TNMStageGroupVS

Messages

InformationValueSet.dateValues for date differ: '2022-12-06T19:49:11+00:00' vs '2022-12-07T17:38:21+00:00'

Metadata

NameValueComments
.compose.inactive
    .compose.lockedDate
      .copyrightThis material contains content from LOINC (http://loinc.org). LOINC is copyright © 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license. LOINC® is a registered United States trademark of Regenstrief Institute, Inc
        .date2022-12-06T19:49:11+00:002022-12-07T17:38:21+00:00
        • Values Differ
        .descriptionValueset indicating the type of staging, clinical or pathological, of breast cancer.
          .experimentalfalse
            .immutable
              .jurisdiction
                ..jurisdiction[0]http://unstats.un.org/unsd/methods/m49/m49.htm#001
                  .nameTNMStageGroupVS
                    .publisherHL7 International - Clinical Interoperability Council Group
                      .purpose
                        .statusactive
                          .titleStaging Type for Stage Group ValueSet
                            .urlhttp://hl7.org/fhir/uv/ichom-breast-cancer/ValueSet/TNMStageGroupVS
                              .version1.0.0-ballot

                                Definition

                                ItemPropertyValueComments
                                .includehttp://loinc.org
                                  ..Concept21908-9Stage group.clinical Cancer
                                    ..Concept21902-2Stage group.pathology Cancer

                                      Expansion

                                      CodeDisplayComments
                                      .21908-9Stage group.clinical Cancer
                                        .21902-2Stage group.pathology Cancer